CFNEUTRAL

P/E Ratio

10.2x

Updated 272h ago

Sector Performance

7th percentile

CF

10.2x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The current P/E (price-to-earnings) ratio of 10.2x means investors are paying $10.20 for every $1 of the company’s annual earnings—a low multiple often associated with value or out-of-favor stocks.

Among sector peers, the median P/E is 23.7x, and CF sits in the 7th percentile, indicating it trades far cheaper than the vast majority of its industry. Over the last quarter, the P/E increased by +7.4% (from 9.4x to 10.2x), and over the prior eight quarters the trend has been rising; year-over-year data is not available. A low P/E combined with a rising trend may signal that earnings are falling faster than the share price is declining, or that the market is beginning to price in a recovery—both scenarios carry risk of further downside if earnings deteriorate further. This metric supports the overall NEUTRAL verdict: the low valuation suggests limited downside, but the upward P/E trend warrants caution until earnings stability is confirmed.

Frequently Asked Questions

What does the P/E Ratio tell investors about CF?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are CF's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master CF's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full CF research report

Free account — no credit card

CF

10.2x

Sector Median

24.7x

Sector Avg

36.0x

How CF's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.